ChartMill assigns a Buy % Consensus number of 85% to PMVP. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | Craig-Hallum | Initiate | Buy |
| 2024-04-12 | Jefferies | Initiate | Buy |
| 2024-03-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-27 | Ladenburg Thalmann | Initiate | Buy |
| 2023-10-16 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-11 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-03-20 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-02 | Oppenheimer | Maintains | Outperform |
| 2022-11-17 | HC Wainwright & Co. | Maintains | Buy |
| 2022-06-09 | Oppenheimer | Maintains | Outperform |
| 2022-05-24 | Goldman Sachs | Maintains | Buy |
| 2022-03-02 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2021-09-22 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2021-08-19 | Oppenheimer | Initiate | Perform |
| 2021-08-02 | Guggenheim | Initiate | Buy |
| 2021-07-29 | HC Wainwright & Co. | Initiate | Buy |
12 analysts have analysed PMVP and the average price target is 8.16 USD. This implies a price increase of 518.18% is expected in the next year compared to the current price of 1.32.
The consensus rating for PMV PHARMACEUTICALS INC (PMVP) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.